Several important oncogenes are located on chromosome 7, including cMET, BRAF and EGFR. Three thyroid cancer cases with activating EGFR mutations have been described, two of which showed a favourable response when treated with EGFR tyrosine-kinase inhibitors [47], [48]. This evidence concerns the gene EGFR and thyroid cancer.